UWM
ABBV icon

USAdvisors Wealth Management’s AbbVie ABBV Stock Holding History

USAdvisors Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,394
Closed -$105K – 85
2019
Q3 		$105K Sell
1,394
-4,348
-76% -$298K 0.05% 58
2019
Q2 		$418 Sell
5,742
-367
-6% -$28.8K 0.18% 35
2019
Q1 		$492K Buy
6,109
+4
+0.1% +$327 0.35% 25
2018
Q4 		$563K Buy
6,105
+4
+0.1% +$352 0.46% 23
2018
Q3 		$577K Sell
6,101
-657
-10% -$62.3K 0.41% 31
2018
Q2 		$626K Buy
6,758
+662
+11% +$64.7K 0.47% 28
2018
Q1 		$577K Buy
6,096
+2
+0% +$220 0.46% 28
2017
Q4 		$589K Buy
+6,094
New +$574K 0.5% 23

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

USAdvisors Wealth Management's ABBV Position: Q4 2019 in Review

USAdvisors Wealth Management sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 1,394 shares — an estimated $105K sold.

USAdvisors Wealth Management first reported a position in ABBV in Q4 2017 and held it in 8 quarters. The position peaked at $626K in Q2 2018. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • USAdvisors Wealth Management reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • USAdvisors Wealth Management sold 1,394 AbbVie shares in Q4 2019, an estimated $105K.
  • USAdvisors Wealth Management first reported a position in AbbVie in Q4 2017 and held it in 8 quarters.
  • USAdvisors Wealth Management's AbbVie position peaked at $626K in Q2 2018.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on USAdvisors Wealth Management's 13F filing for Q4 2019, filed 14 Feb 2020.